{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T14:56:43Z","timestamp":1778511403309,"version":"3.51.4"},"reference-count":15,"publisher":"BMJ","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pract Neurol"],"published-print":{"date-parts":[[2013,8]]},"abstract":"<jats:p>Ipilimumab enhances the T lymphocyte mediated immune response to both tumour cells and healthy tissue, improving survival in patients with metastatic melanoma but also leads to more immune-related adverse events (irAEs) than previously used treatments, such as dacarbazine. We present three patients with neurological irAEs from ipilimumab treatment: hypophysitis, meningitis and Guillain\u2013Barr\u00e9 syndrome. Once an irAE occurs, ipilimumab should be stopped and corticosteroids started. Usually, ipilimumab-induced irAE symptoms improve within days to weeks, but can be life-threatening if unrecognised.<\/jats:p>","DOI":"10.1136\/practneurol-2012-000447","type":"journal-article","created":{"date-parts":[[2013,3,13]],"date-time":"2013-03-13T23:28:16Z","timestamp":1363217296000},"page":"278-280","source":"Crossref","is-referenced-by-count":111,"title":["Neurological immune-related adverse events of ipilimumab"],"prefix":"10.1136","volume":"13","author":[{"given":"Ilja","family":"Bot","sequence":"first","affiliation":[{"name":"Department of Neurology, Antoni van Leeuwenhoek Hospital\/Netherlands Cancer Institute, Amsterdam, The Netherlands"},{"name":"Department of Neurology, University Medical Centre Nijmegen St Radboud, Nijmegen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian U","family":"Blank","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Antoni van Leeuwenhoek Hospital\/Netherlands Cancer Institute, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Willem","family":"Boogerd","sequence":"additional","affiliation":[{"name":"Department of Neurology, Antoni van Leeuwenhoek Hospital\/Netherlands Cancer Institute, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dieta","family":"Brandsma","sequence":"additional","affiliation":[{"name":"Department of Neurology, Antoni van Leeuwenhoek Hospital\/Netherlands Cancer Institute, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2013,3,13]]},"reference":[{"key":"2025090410372358000_13.4.278.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1003466"},{"key":"2025090410372358000_13.4.278.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1104621"},{"key":"2025090410372358000_13.4.278.3","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-008-0653-8"},{"key":"2025090410372358000_13.4.278.4","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-009-0193-z"},{"key":"2025090410372358000_13.4.278.5","doi-asserted-by":"publisher","DOI":"10.1016\/S1043-2760(96)00270-6"},{"key":"2025090410372358000_13.4.278.6","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A1623"},{"key":"2025090410372358000_13.4.278.7","doi-asserted-by":"publisher","DOI":"10.1097\/CJI.0b013e318156e47e"},{"key":"2025090410372358000_13.4.278.8","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.04.5716"},{"key":"2025090410372358000_13.4.278.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2004.04.006"},{"key":"2025090410372358000_13.4.278.10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2567.2004.01821.x"},{"key":"2025090410372358000_13.4.278.11","doi-asserted-by":"publisher","DOI":"10.1006\/clim.1998.4684"},{"key":"2025090410372358000_13.4.278.12","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdr028"},{"key":"2025090410372358000_13.4.278.13","doi-asserted-by":"crossref","unstructured":"Bompaire F Mateus C Taillia H . Severe meningo-radiculo-nevritis associated with ipilimumab. Invest New Drugs 2012.","DOI":"10.1007\/s10637-011-9787-1"},{"key":"2025090410372358000_13.4.278.14","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1017\/S0317167100007939","article-title":"Autoimmune inflammatory myopathy after treatment with ipilimumab","volume":"36","author":"Hunter","year":"2009","journal-title":"Can J Neurol Sci"},{"key":"2025090410372358000_13.4.278.15","doi-asserted-by":"publisher","DOI":"10.1097\/CJI.0b013e318193a206"}],"container-title":["Practical Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/practneurol-2012-000447","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T17:37:35Z","timestamp":1757007455000},"score":1,"resource":{"primary":{"URL":"https:\/\/pn.bmj.com\/lookup\/doi\/10.1136\/practneurol-2012-000447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,13]]},"references-count":15,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2013,7,4]]},"published-print":{"date-parts":[[2013,8]]}},"alternative-id":["10.1136\/practneurol-2012-000447"],"URL":"https:\/\/doi.org\/10.1136\/practneurol-2012-000447","relation":{},"ISSN":["1474-7758","1474-7766"],"issn-type":[{"value":"1474-7758","type":"print"},{"value":"1474-7766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,13]]}}}